biostudies-literatureUnknown102(4)Gupta SNIDDK NIH HHSNIGMS NIH HHSKidney international930-935https://www.ebi.ac.uk/biostudies/studies/S-EPMC9523226biostudies-literatureAcute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.PMC9523226K08 DK120868U54 GM115428Shin DSHirsch JSReynolds KLHsu RKFelip EStrohbhen IAKitchlu AShah CVMadhavan SMIsik BKisel ABeckerman PBagnis CIWauters ESise MEOstermann MPage VHerrmann SMYoung TGlezerman IGRenaghan ADJhaveri KDBermejo SSchmidt-Ott KMRigg AAggarwal VOrtiz-Melo DIMothi SSLee MProsek JMMamlouk OMooradian MJCennamo AICPi-AKI ConsortiumStrohbehn IABenesova KLeaf DEGupta SSoler MJDonley VKibbelaar ZAChang WLoew SLumlertgul NDeshpande PMunoz-Couselo Ede Seigneux SKansal SKRangarajan SZuo YShort SAPHogan JJSakhiya VSeethapathy REijgelsheim MMini SSprangers BOwen DHSingh HGarcia-Carro CChang WTKaghazchi AWang QCarreras MJWu SMalik ABCarter KHusain MMithani ZSeethapathy HSAnand SHanna PETio MCGarcia PPagan JAShaunak NMotwani SSCarlos CAGaughan EMKhanin YAbudayyeh ACortazar FBMurakami NSelamet UCampedel LStalbow DCoppock GChandra SWanchoo RCherry GSeylanova NCigoi HLin JSRashidi AWeins AAlbert NDe Seigneux SKoessler TSalem JEfalseAcute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.2022-01-01T00:00:00Z2022 Oct2025-04-05T09:42:31.368Z2025-04-05T09:42:31.368ZS-EPMC95232263596480010.1016/j.kint.2022.07.019